State Street’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

State Street’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,931,809	Closed	-$83.6M	–	3737
2014 Q4	$83.6M	Sell	4,931,809 -1,037,333	-17%	-$14.6M	0.01%	933
2014 Q3	$71.2M	Sell	5,969,142 -735,424	-11%	-$5.02M	0.01%	998
2014 Q2	$37.8M	Sell	6,704,566 -162,595	-2%	-$749K	﹤0.01%	1378
2014 Q1	$25.2M	Sell	6,867,161 -1,723,065	-20%	-$6.57M	﹤0.01%	1604
2013 Q4	$28.9M	Buy	8,590,226 +3,245,771	+61%	+$13.4M	﹤0.01%	1508
2013 Q3	$22.7M	Buy	5,344,455 +2,275,558	+74%	+$10.8M	﹤0.01%	1617
2013 Q2	$14.1M	Buy	+3,068,897	New	+$10.5M	﹤0.01%	1846

State Street's AVNR Position: Q1 2015 in Review

State Street sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 4,931,809 shares — an estimated $83.6M sold.

State Street first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $83.6M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

State Street reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
State Street sold 4,931,809 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $83.6M.
State Street first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
State Street's AVANIR PHARMACEUTICALS, INC CL A position peaked at $83.6M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on State Street's 13F filing for Q1 2015, filed 15 May 2015.